- Three-month selection
- $112 first month, then $127/month
- Monthly selection
- $120 first month, then $135/month
- Route
- Nasal spray
- Bottle volume
- Not verified in the reviewed catalog
- Access
- Prescription after clinician assessment
Keep the route and plan together
Eden's NAD+ nasal spray is a distinct offer within a catalog that also contains injections and a cream. The three-month nasal selection shows $112 for the first month and $127 per month afterward. The monthly selection displays $120 initially and $135 subsequently. Those pairs are more informative than describing the product simply as a $112 spray.
Readers should keep the plan length attached to the price whenever sharing or saving a comparison. Otherwise, someone selecting monthly payments or a different commitment may reasonably expect a rate that was only advertised under another option.
What the price difference means
The continuing displayed rates differ by $8 per month between the two nasal selections. That comparison says something about the advertised purchasing arrangements, but it does not reveal the size of the initial payment or establish a universal saving. The longer option may carry a different upfront commitment, so request the actual payment calendar.
If a year consisted of one $112 month and eleven $127 months, the simple scenario would total $1,509. This is arithmetic for the displayed rates, not a promised annual bill or a recommendation to continue treatment for twelve months.
The bottle still needs a specification
The reviewed catalog does not establish the nasal bottle volume. It also does not let us infer the amount delivered by each pump actuation. We therefore leave volume blank and avoid a price-per-milliliter ranking. Unknown is more useful than a precise number borrowed from a different brand's spray.
Before enrollment, ask for the concentration, bottle quantity, device instructions and refill expectations of the actual prescription. A monthly financial label can coexist with a supply period that depends on prescribed use. The clinician and dispensing pharmacy should resolve that relationship rather than a comparison calculator.
Think through delivery and interruptions
Eden advertises free shipping and provider support. For a nasal product, ask how it should be stored during normal use and travel, and what to do if the pump stops working or a shipment is delayed. The answer should concern the actual preparation, not a general rule for all nasal medicines.
Also verify how to pause a future refill and whether stopping a renewal affects access to follow-up. A patient may need clinical advice after deciding not to continue purchasing. Clear contact and cancellation arrangements help avoid confusing the subscription status with the medical plan.
A convenience preference is not efficacy evidence
A person may reasonably prefer a spray to an injection. That preference does not establish that nasal NAD+ improves cognition, produces the same exposure as an injectable or is safer for every user. The route-specific evidence and the patient's health context remain part of the consultation.
Our assessment is that Eden supplies useful paired prices but still requires a product-specific quote to complete the comparison. Check the first charge, renewal rate, bottle information and commitment together. The spray should be judged on those concrete terms and an honest discussion of evidence, rather than on claims attached to the wider NAD+ collection or another formulation.
Useful distinctions
- Introductory and later rates are visible
- Monthly and longer selections can be compared
- Nasal format is clearly separate from injections
Limitations to weigh
- Bottle volume remains unverified
- Three-month billing schedule requires clarification
- Route convenience does not establish cognitive benefit
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.